{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T09:53:13Z","timestamp":1787910793551,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009726","name":"Foundation for Angelman Syndrome Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Angelman syndrome (AS) is a rare neurogenetic disorder characterized by persistent cognitive and functional impairments that necessitate lifelong care. Caring for individuals with AS leads to substantial household costs, as well as impacts on work productivity, leisure time, and quality of life for caregivers. The economic value of these impacts in the United States (US) has not been well studied. We conducted a survey of US caregivers for persons with AS to quantify the annual economic impact of caregiving. Information on AS-related economic impacts was gathered, including household costs, employment impacts, leisure time loss, and caregiver healthcare costs. The survey did not gather information on direct medical care costs borne by healthcare insurers or other economic impacts to the US government and other stakeholders.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 105 caregivers completed the survey and 105 individuals with AS were represented. Most caregivers were female (89.5%), white (83.8%), and identified as the primary caregiver (75.2%). Most individuals with AS represented in the sample were age\u2009&lt;\u200918 (82.9%). The annual economic impact of caregiving for persons with AS averaged $79,837 (SD $55,505). Costs related to employment impacts and lost work productivity in the past 12 months accounted for most (53%) of this impact and averaged $42,697 (SD $28,309). Household costs incurred in the past 12 months for goods and services to better accommodate individuals with AS were $29,680 (SD $47,753). Leading contributors included vehicle purchases and modifications (mean $6,717; SD $17,791), professional caregiving (mean $6,123; SD $17,335), home modifications and repairs (mean $4,387; SD $15,734), and supportive therapy (mean $3,269; SD $7,564). Economic impacts in the past 12 months from lost leisure time and incremental healthcare costs for caregivers were estimated to be $6,634 (SD $4,652) and $827 (SD $2,072), respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Caregivers incur substantial costs to accommodate individuals with AS, as well as substantial impacts related to employment and leisure time. This study\u2019s findings may be utilized in future research to better estimate the value from therapeutic advances in AS and direct resources toward mitigating economic impacts for households.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03551-4","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:32:52Z","timestamp":1740151972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The economic impact of caregiving for individuals with Angelman syndrome in the United States: results from a caregiver survey"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9126-2534","authenticated-orcid":false,"given":"John","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Chertavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marric","family":"Buessing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Renteria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufei","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Tones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"issue":"3","key":"3551_CR1","doi-asserted-by":"publisher","first-page":"e1843","DOI":"10.1002\/mgg3.1843","volume":"10","author":"J Duis","year":"2022","unstructured":"Duis J, Nespeca M, Summers J, Bird L, Bindels-de Heus K, Valstar MJ, et al. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med. 2022;10(3):e1843.","journal-title":"Mol Genet Genomic Med"},{"key":"3551_CR2","unstructured":"Angelman Syndrome. https:\/\/rarediseases.org\/rare-diseases\/angelman-syndrome\/."},{"issue":"3\u20135","key":"3551_CR3","first-page":"100","volume":"2","author":"A Dagli","year":"2012","unstructured":"Dagli A, Buiting K, Williams CA. Molecular and clinical aspects of Angelman syndrome. Mol Syndromol. 2012;2(3\u20135):100\u201312.","journal-title":"Mol Syndromol"},{"issue":"1","key":"3551_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13023-017-0716-z","volume":"12","author":"AC Wheeler","year":"2017","unstructured":"Wheeler AC, Sacco P, Cabo R. Unmet clinical needs and burden in Angelman syndrome: a review of the literature. Orphanet J Rare Dis. 2017;12(1):164.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"3551_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2006","unstructured":"Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140(5):413\u20138.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"3551_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/ajmg.a.38694","volume":"176","author":"A Prasad","year":"2018","unstructured":"Prasad A, Grocott O, Parkin K, Larson A, Thibert RL. Angelman syndrome in adolescence and adulthood: a retrospective chart review of 53 cases. Am J Med Genet A. 2018;176(6):1327\u201334.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"3551_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ajmg.a.36864","volume":"167A","author":"AM Larson","year":"2015","unstructured":"Larson AM, Shinnick JE, Shaaya EA, Thiele EA, Thibert RL. Angelman syndrome in adulthood. Am J Med Genet A. 2015;167A(2):331\u201344.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"3551_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40271-018-0323-7","volume":"12","author":"JC Grieco","year":"2019","unstructured":"Grieco JC, Romero B, Flood E, Cabo R, Visootsak J. A conceptual model of Angelman syndrome and review of relevant clinical outcomes assessments (COAs). Patient. 2019;12(1):97\u2013112.","journal-title":"Patient"},{"issue":"4","key":"3551_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s10578-020-01051-z","volume":"52","author":"T Willgoss","year":"2021","unstructured":"Willgoss T, Cassater D, Connor S, Krishnan ML, Miller MT, Dias-Barbosa C, et al. Measuring what matters to individuals with Angelman syndrome and their families: development of a patient-centered disease concept model. Child Psychiatry Hum Dev. 2021;52(4):654\u201368.","journal-title":"Child Psychiatry Hum Dev"},{"key":"3551_CR10","unstructured":"Ferreira T, Brites R, Brand\u00e3o T, Nunes O, Hip\u00f3lito J. Burden and parental satisfaction in informal caregivers of people with Angelman syndrome: a mix-method study. Medit J Clin Psychol. 2022;10(2)."},{"issue":"9","key":"3551_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1111\/jir.12195","volume":"59","author":"N Miodrag","year":"2015","unstructured":"Miodrag N, Peters S. Parent stress across molecular subtypes of children with Angelman syndrome. J Intellect Disabil Res. 2015;59(9):816\u201326.","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"3551_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13023-019-1210-6","volume":"14","author":"N Khan","year":"2019","unstructured":"Khan N, Cabo R, Tan WH, Tayag R, Bird LM. An observational study of pediatric healthcare burden in Angelman syndrome: results from a real-world study. Orphanet J Rare Dis. 2019;14(1):239.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"3551_CR13","doi-asserted-by":"publisher","first-page":"101423","DOI":"10.1016\/j.dhjo.2022.101423","volume":"16","author":"SL Hartmanis","year":"2023","unstructured":"Hartmanis SL, Baker EK, Godler DE, Liew D. Estimating the impact of Angelman syndrome on parental productivity in Australia using productivity-adjusted life years. Disabil Health J. 2023;16(2):101423.","journal-title":"Disabil Health J"},{"issue":"4","key":"3551_CR14","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s10803-021-05193-4","volume":"53","author":"EK Baker","year":"2023","unstructured":"Baker EK, Arora S, Amor DJ, Date P, Cross M, O\u2019Brien J, et al. The cost of raising individuals with fragile X or chromosome 15 imprinting disorders in Australia. J Autism Dev Disord. 2023;53(4):1682\u201392.","journal-title":"J Autism Dev Disord"},{"key":"3551_CR15","unstructured":"Reflecting Poorly: Health Care in the U.S. Compared to Other High-Income Countries. The Commonwealth Fund; 2021."},{"issue":"1","key":"3551_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","volume":"17","author":"G Yang","year":"2022","unstructured":"Yang G, Cintina I, Pariser A, Oehrlein E, Sullivan J, Kennedy A. The national economic burden of rare disease in the United States in 2019. Orphanet J Rare Dis. 2022;17(1):163.","journal-title":"Orphanet J Rare Dis"},{"key":"3551_CR17","unstructured":"FAST (Foundation for Angelman Syndrome Therapeutics) https:\/\/cureangelman.org\/."},{"key":"3551_CR18","unstructured":"ASF (Angelman Syndrome Foundation). https:\/\/www.angelman.org\/."},{"key":"3551_CR19","unstructured":"Global Angelman Syndrome Registry 2023. https:\/\/www.angelmanregistry.info\/."},{"key":"3551_CR20","unstructured":"Global Angelman Registry: FAST Australia; 2023. https:\/\/cureangelman.org.au\/global-angelman-registry\/."},{"issue":"6","key":"3551_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1524-4733.2009.00542.x","volume":"12","author":"ER Giovannetti","year":"2009","unstructured":"Giovannetti ER, Wolff JL, Frick KD, Boult C. Construct validity of the Work Productivity and Activity Impairment questionnaire across informal caregivers of chronically ill older patients. Value Health. 2009;12(6):1011\u20137.","journal-title":"Value Health"},{"key":"3551_CR22","unstructured":"Hoefman R, Van Exel N, Brouwer W. iMTA Valuation of Informal Care Questionnaire (iVICQ). Version 1.1 Rotterdam: iBMG \/ iMTA; 2013. https:\/\/www.imta.nl\/assets\/uploads\/2022\/01\/iVICQ_UK_version_1.1.pdf."},{"issue":"8","key":"3551_CR23","first-page":"1933","volume":"44","author":"R Hoefman","year":"2014","unstructured":"Hoefman R, Payakachat N, van Exel J, Kuhlthau K, Kovacs E, Pyne J, et al. Caring for a child with autism spectrum disorder and parents\u2019 quality of life: application of the CarerQol. J Autism Dev Disord. 2014;44(8):1933\u201345.","journal-title":"J Autism Dev Disord"},{"key":"3551_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s40273-019-00789-2","volume":"37","author":"C Brown","year":"2019","unstructured":"Brown C, Tilford J, Payakachat N, Williams D, Kuhlthau K, Pyne J, et al. Measuring health spillover effects in caregivers of children with autism spectrum disorder: a comparison of the EQ-5D-3L and SF-6D. Pharmacoeconomics. 2019;37:609\u201320.","journal-title":"Pharmacoeconomics"},{"key":"3551_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10803-019-04249-w","volume":"50","author":"L ten Hoopen","year":"2020","unstructured":"ten Hoopen L, de Nijs P, Duvekot J, Greaves-Lord K, Hillegers M, Brouwer W, et al. Children with an autism spectrum disorder and their caregivers: capturing health-related and care-related quality of life. J Autism Dev Disord. 2020;50:263\u201377.","journal-title":"J Autism Dev Disord"},{"key":"3551_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jcf.2017.08.016","volume":"17","author":"C Fitzgerald","year":"2018","unstructured":"Fitzgerald C, George S, Somerville R, Linnane B, Fitzpatrick P. Caregiver burden of parents of young children with cystic fibrosis. J Cyst Fibros. 2018;17:125\u201331.","journal-title":"J Cyst Fibros"},{"key":"3551_CR27","unstructured":"United States Department of Labor BoLS. July 2023 employment situation. August 4, 2023."},{"issue":"6","key":"3551_CR28","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/WNL.0000000000000669","volume":"83","author":"E Landfeldt","year":"2014","unstructured":"Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, et al. The burden of Duchenne muscular dystrophy: an international, cross-sectional study. Neurology. 2014;83(6):529\u201336.","journal-title":"Neurology"},{"issue":"4","key":"3551_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s40273-019-00784-7","volume":"37","author":"JC Jacobs","year":"2019","unstructured":"Jacobs JC, Van Houtven CH, Tanielian T, Ramchand R. Economic spillover effects of intensive unpaid caregiving. Pharmacoeconomics. 2019;37(4):553\u201362.","journal-title":"Pharmacoeconomics"},{"key":"3551_CR30","unstructured":"CPI Inflation Calculator: United States Bureau of Labor Statistics. https:\/\/www.bls.gov\/data\/inflation_calculator.htm."},{"issue":"3","key":"3551_CR31","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mus.23942","volume":"49","author":"J Larkindale","year":"2014","unstructured":"Larkindale J, Yang W, Hogan PF, Simon CJ, Zhang Y, Jain A, et al. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve. 2014;49(3):431\u20138.","journal-title":"Muscle Nerve"},{"key":"3551_CR32","unstructured":"Income in the United States: 2022. United States Census Bureau, Department of Commerce."},{"issue":"7","key":"3551_CR33","doi-asserted-by":"publisher","first-page":"e00734","DOI":"10.1002\/mgg3.734","volume":"7","author":"N Khan","year":"2019","unstructured":"Khan N, Cabo R, Tan WH, Tayag R, Bird LM. Healthcare burden among individuals with Angelman syndrome: findings from the Angelman syndrome natural history study. Mol Genet Genomic Med. 2019;7(7):e00734.","journal-title":"Mol Genet Genomic Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03551-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:32:59Z","timestamp":1740151979000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03551-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3551"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03551-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"9 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval to conduct this study was provided by Mater Research and the Global Angelman Syndrome Registry Governance Board, which oversees research access to de-identified registry data. Informed consent was obtained from all caregivers prior to initiation of the survey.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JJ, EC, MB, TR, and LT are employees of Medicus Economics, LLC, which received consulting fees from the Foundation for Angelman Syndrome Therapeutics (FAST).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}